Results 31 to 40 of about 40,820 (211)

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas, Hoffmann, Rainer, Köster, Ralf, Pohl, Tilmann   +5 more
core   +2 more sources

Novel use of cutting balloon to manage compressive subintimal hematoma during left main stenting in a patient with spontaneous coronary artery dissection

Clinical Case Reports, 2018
Key Clinical Message Spontaneous coronary artery dissection (SCAD) is a common cause of acute coronary syndrome particularly in younger women. Good outcomes with conservative management are generally expected.
Brent M. McGrath, Minh N. Vo
doaj   +1 more source

Entrapped inflated coronary balloon with a disrupted shaft

IHJ Cardiovascular Case Reports, 2021
Entrapment of an undeflatable angioplasty balloon is a rare yet fatal complication of modern percutaneous coronary intervention that can lead to fatal sequelae such as myocardial infarction and life-threatening arrhythmia.
Karthik Tummala, Sivarama Krishna Arikeri   +1 more
doaj   +1 more source

Rupture of the arterial wall causes deflection in pressure time course during ex vivo balloon angioplasty [PDF]

, 1997
A relation between restenosis and arterial lesions resulting from balloon angioplasty has been suggested in literature. Nevertheless, it is unclear to what extent angioplasty-induced arterial wall lesions contribute to the occurrence of restenosis.
Boom, Herman B.K., Havenith, Miek G., Poortermans, Cees J., Steenhuijsen, Jacco L.G., Vaartjes, Simon R.   +4 more
core   +3 more sources

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty.
Sacharias von Koch, Mikael Zhou, Hans Christian Rosén, Sammy Zwackman, Juliane Jurga, Per Grimfjärd, Matthias Götberg, Moman A. Mohammad, David Erlinge   +8 more
doaj   +1 more source

Prolonged versus brief balloon inflation during arterial angioplasty for de novo atherosclerotic disease: a systematic review and meta-analysis

CVIR Endovascular, 2019
Objective Angioplasty is a fundamental treatment for atherosclerotic disease and may be performed as the sole therapy in small vessel disease. However, the ideal duration of balloon inflation has not yet been identified.
Mark Rockley, Prasad Jetty, Aleksandar Radonjic, Kathleen Rockley, George Wells, Dean Fergusson   +5 more
doaj   +1 more source

POT-sideDCB-POT: A novel technique for treating coronary bifurcation lesions

Hellenic Journal of Cardiology, 2021
The rePOT technique is a novel and easily applied approach for coronary bifurcations. Drug-Coated Balloon (DCB) angioplasty is increasingly being utilized in management of small vessels and coronary bifurcation lesions.
Georgios Tzanis, Athanasios Kolyviras, Francesco Giannini, Antonio Colombo, Vaios Tzifos   +4 more
doaj   +1 more source

Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis [PDF]

, 2007
Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis after an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered.
Abrams, Keith R., Asseburg, Christian, de Belder, Mark, Fenwick, Elisabeth, Palmer, Stephen, Sculpher, Mark, Vergel, Yolanda Bravo   +6 more
core   +4 more sources

Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty [PDF]

, 1993
Major, adverse cardiac events (death, myocardial infarction, bypass surgery and reintervention) occur in 4 to 7% of all patients undergoing coronary balloon angioplasty. Prospectively collected clinical data, and angiographic quantitative and qualitative
Balcon, R. (Rafael), Danchin, N. (Nicolas), Feyter, P.J. (Pim) de, Foley, D.P. (David), Hanet, C. (Claude), Hermans, W.R.M. (Walter), Heyndrickx, G.R. (Guy), Lablanche, J.M. (Jean Marc), Mast, E.G. (Gijs), Rafflenbeul, W., Rensing, B.J.W.M. (Benno), Rutsch, W.R. (Wolfgang), Serruys, P.W.J.C. (Patrick), Uebis, R.   +13 more
core   +1 more source

Ischemia Modified Albumin levels in patients with Stable Angina Pectoris who underwent Percutaneous Coronary Intervention

Majalah Kardiologi Indonesia, 2007
Background. Ischemia Modified Albumin (IMA) is a biomarker of myocardial ischemia. Blood levels of IMA rise in patients who develop ischemia during percutaneous coronary intervention (PCI).
Hariadi Hariawan, Otte J Rachman, Yoga Yuniadi   +2 more
doaj   +1 more source